Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

54.16

+0.66 (1.23%)

as of Jun 5, 2026, 3:33:54 pm Market Open.

1636 watching

Investor Insights

Jun 5, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) is viewed positively by several analysts, who note its solid growth in Asia and the wealth management sector. The company is seen as a stable and reliable option, with a decent dividend yield that appeals to income-focused investors. Analysts acknowledge that while MFC has experienced some recent challenges, especially in its U.S. operations and corrections after strong performances, it maintains a healthy growth outlook. Concerns about the overall market and macroeconomic factors have led to suggestions of caution, but many believe MFC's valuation is still attractive relative to its peers, particularly the banks. In the long term, it remains a compelling investment opportunity with the potential for growth, other factors such as credit risk being minimal.

Consensus

Positive

Valuation

Fair Value

Similar

SLF

BUY

Has a lot going for it. Likes their far Eastern operations.

BUY

Good management. Expect they will take a lot of costs out of the business with the acquisition of John Hancock. Expecting good Asian growth.

BUY ON WEAKNESS

Should be about to put up some good growth in earnings with their John Hancock acquisition. Expect some selling pressure when Hancock shareholders get their Manulife shares and start selling them. That will be an opportunity to buy.

BUY

Likes the life insurance business, this company in particular. Strong management. Expect they will be ruthless in cutting costs in John Hancock.

BUY

The merger with John Hancock was good and at a reasonable price. This should create cost synergies. Has a strong global presence.

BUY

Likes the insurance industry. Very solid company and well managed. A good hold.

BUY

The Hancock acquisition will add a lot over the next couple of years. Likes their position in Asia as well.

PAST TOP PICK

(A top pick December 16/03. Up 11.5%.) They consolidate very well. Good earnings.

DON'T BUY

Has done a very good job in its acquisition strategy. Will have some digesting problems with the John Hancock acquisition.

BUY

Can go a lot higher now that they John Hancock shareholders have agreed to the sale. Asian assets are now profitable. A good long-term hold.

BUY

Likes the insurance area.

BUY

Not keen on this stock. Feels they are operating in the high risk areas in Asia. Also feels the John Hancock acquisition won't work out as well as expected.

BUY

Was a pullback, because a lot of institutional investors which owned John Hancock word divesting their holdings. Feels the Asian side of the business is the important part.

BUY

Likes the business model very much. Good growth in Asia. Their last quarter was terrific.

HOLD

Do own some. At it's all time high. See no reason to sell. Hold.

Showing 2,026 to 2,040 of 2,279 entries

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Darren Sissons

Campbell Lee & Ross

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)